Episodios

  • Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
    May 6 2025

    Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.

    CME information and select publications here.

    Más Menos
    1 h
  • Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress
    Apr 26 2025

    Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events.

    NCPD information and select publications here.

    Más Menos
    1 h y 33 m
  • Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
    Apr 25 2025

    Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions.

    CME information and select publications here.

    Más Menos
    53 m
  • HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
    Apr 21 2025

    Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer. 

    CME information and select publications here.

    Más Menos
    1 h y 40 m
  • HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit
    Apr 13 2025

    Clinical investigators discuss available data guiding the management of hormone receptor-positive metastatic breast cancer.

    CME information and select publications here.

    Más Menos
    1 h y 59 m
  • Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates
    Apr 8 2025

    Dr Adrienne G Waks from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews recent trial updates and their significance for the management of breast cancer.

    CME information and select publications here.

    Más Menos
    55 m
  • Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel
    Mar 28 2025

    Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1.

    CME information and select publications here.

    Más Menos
    49 m
  • HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy
    Mar 28 2025

    Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes data presented at the recent 2024 San Antonio Breast Cancer Symposium applicable to the management of HR-positive breast cancer.

    CME information and select publications here.

    Más Menos
    1 h y 3 m
adbl_web_global_use_to_activate_T1_webcro805_stickypopup